Medullary thyroid cancer: molecular factors, management and treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Medullary thyroid cancer: molecular factors, management and treatment

Published:2021-04-01 Issue:3 Volume:61 Page:681-686
ISSN:1220-0522
Container-title:Romanian Journal of Morphology and Embryology
language:
Short-container-title:Rom J Morphol Embryol

Author:

Pavlidis Efstathios, ,Sapalidis Konstantinos,Chatzinikolaou Fotios,Kesisoglou Isaak, , ,

Publisher

Societatea Romana de Morfologie

Subject

Cell Biology,Developmental Biology,Embryology,General Medicine,Pathology and Forensic Medicine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thyroid Malignancy and Cutaneous Lichen Amyloidosis: Key Points Amid RET Pathogenic Variants in Medullary Thyroid Cancer/Multiple Endocrine Neoplasia Type 2 (MEN2);International Journal of Molecular Sciences;2024-09-10

2. LINC00887 Acts as an Enhancer RNA to Promote Medullary Thyroid Carcinoma Progression by Binding with FOXQ1;Current Cancer Drug Targets;2023-11-20

3. Current understanding of pathogenetic mechanisms in neuroendocrine neoplasms;Expert Review of Endocrinology & Metabolism;2023-11-07

4. Dihydroartemisinin inhibits EMT progression in medullary thyroid carcinoma through Hippo signaling pathway regulated by IL-6;2023-10-24

5. Update on the Diagnosis and Management of Medullary Thyroid Cancer: What Has Changed in Recent Years?;Cancers;2022-07-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP